2-(2,5-dimethoxyphenyl)ethanamine has been researched along with amphetamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, GM; Glennon, RA; Liebowitz, SM | 1 |
Dowd, CS; DuPre, A; Egan, C; Glennon, RA; Herrick-Davis, K; Smith, C; Teitler, M | 1 |
Glennon, RA | 1 |
3 other study(ies) available for 2-(2,5-dimethoxyphenyl)ethanamine and amphetamine
Article | Year |
---|---|
Serotonin receptor affinities of psychoactive phenalkylamine analogues.
Topics: Amines; Animals; Female; Hallucinogens; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Receptors, Serotonin; Stomach; Structure-Activity Relationship | 1980 |
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
Topics: 3T3 Cells; Animals; Cell Line; Inositol Phosphates; Ligands; Mice; Propylamines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 2000 |
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |